Main Sector
Biotech Subsector
Medtech Subsector
Diagnostics Subsector
Indications
Biotech Phase of Development
Medtech/Diagnostic Phase of Development
Index
Countries
Reset

Alex Blanchot

Business France

Ben Bradford

Massachusetts Life Sciences Center.
Director for Business Development 

Isidora Errazuriz

Amcham Chile
Project Coordinator 

Stephanie Fertig

National Institute of Health (NIH)
Program Director, NINDS Small Business Programs, NINDS 
Bio

Stephanie J. Fertig joined the National Institute of Neurological Disorders and Stroke (NINDS) in 2004 and currently serves as the Director for the NINDS Small Business Programs, which includes both small business innovative research (SBIR) and small business technology transfer (STTR) projects. Prior to this role, Ms. Fertig was part of the Repair and Plasticity cluster at NINDS, where her primary scientific interests included neural engineering and neuroprosthesis, as well as traumatic brain injury. Before coming to NINDS, Ms. Fertig earned a B.S. degree in Chemistry with a major in Physics from the University of Virginia, Charlottesville. After completing her degree, she joined Nova Research, Inc. and worked as a researcher in the Center for Bio/Molecular Science and Engineering at the Naval Research Laboratory (NRL) in Washington D.C. At NRL she contributed to multiple bioengineering projects, including the development of molecular switches, microbial fuel cells, microfluidics for use in biosensor applications, and a wide variety of biosensor systems. Ms. Fertig also received a M.B.A. from the University of Maryland's Robert H. Smith School of Business in 2007.

Daniel Gossett

National Institute of Health (NIH)
Program Director, National Institute of Diabetes and Digestive and Kidney Diseases 

Todd Haim

National Institute of Health (NIH)
Program Director 

XinXin Li

US-China Innovation Alliance (UCIA) helps healthcare companies connect to Chinese capital and partners. Through online and offline platforms, we can help healthcare companies worldwide get access to investors, manufacturers, clinical and research partners and important industrial players.


BiotoChina online pitch (www.biotochina.com): present to Chinese investors from your own computer (Selection required, free to attend)


InnoSTARS competition (http://www.uschinainnovation.org/innostars/): Semi-finalists can go to China for an all-expenses-paid 7-day business trip with arranged meetings. Finalists can get cash prize up to $60,000 and more in investment, great promotion opportunity and be introduced to targeted investors. (Free to apply, InnoSTARS 2018 opens in Jan, 2018)


US China Innovation and Investment Summit (UCIS) (http://uschinainnovation.org/ucis/): Learn about trend of China oversea investment and meet Chinese investors in Houston. Pre-arrange meetings through matchmaking systems. (UCIS 2018 will be held in May, 2018)


The US-China Innovation Alliance (UCIA) is a non-profit 501(c)(3) tax-exempt organization that promotes innovation through the exchange of ideas and collaboration between China and the US. We organize the annual US-China Innovation and Investment Summit (UCIS) in Houston, which provides a unique opportunity for innovative technology startups to connect with investors, strategic partners, leading incubators/accelerators, and professional services firms from China. It is an excellent platform for technology companies to leverage significant resources from China to accelerate their growth and to expand their market potential. In 2017, we launched the InnoSTARS Competition, which allows growth-stage technology companies in five core industry areas to compete for the chance to win attendance to UCIS as well as an all-expenses-paid roadshow to China, where they will have an opportunity to showcase their business and products to a wide audience of qualified potential investors and relevant partners. The UCIA also organizes roadshows to bring innovative US technology companies to China for B2B matchmaking and provides other services to help US-based companies connect with complimentary Chinese resources.

Website:
http://www.uschinainnovation.org/innostars/
Main Sector
Diagnostics Subsector
Biotech Phase of Development
Medtech/Diagnostic Phase of Development
Year Founded
2015
XinXin Li
US China Innovation Alliance
Director 
Bio

 Xinxin is founding director of US China Innovation Alliance (UCIA) and currently serves as Director of Development. She is responsible for outreach and partnership of UCIA and oversees various programs including InnoSTARS Competition and BiotoChina online pitch, focusing specifically in healthcare and biotechnology. Xinxin earned a B.S. in Chemistry from Peking University from China and an M.S.P.H in Environmental Health from University of North Carolina at Chapel Hill.

Stephanie Marrus

UCSF Entrepreneurship Center
Director 

Stephen McCarthy

Massachusetts Medical Device Development Center (M2D2)
Founder & Co-Director 

Lorena Palomo

Amcham Chile
COO